amendment_0002_v2.pdf

PDF 327 KB Posted

Attached to
Olanzapine
Solicitation number
spe2d2-19-r-0042
Issued by

About this file

Amendment 0002

View the file

Other files

Show all 12

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

X

AMENDMENT OF SOLICITATION/MODIFICATION OF CONTRACT 1. CONTRACT ID CODE PAGE 1 OF 3

2. AMENDMENT/MODIFICATION NO.

3. EFFECTIVE DATE 4. REQUISITION/PURCHASE REQ. NO.

See Block 14

5. PROJECT NO. (If applicable)

6. ISSUED BY CODE SPE2D2 7. ADMINISTERED BY (If other than Item 6) CODE

DLA TROOP SUPPORT

MEDICAL SUPPLY CHAIN FSGB

700 ROBBINS AVENUE

PHILADELPHIA PA 19111

8. NAME AND ADDRESS OF CONTRACTOR (No., street, county, State and ZIP Code) (X) 9A. AMENDMENT OF SOLICITATION NO.

SPE2D219R0042

9B. DATED (SEE ITEM 11)

2019 APR 30

10A. MODIFICATION OF CONTRACT/ORDER NO.

10B. DATED (SEE ITEM 13)

CODE FACILITY CODE

11. THIS ITEM ONLY APPLIES TO AMENDMENTS OF SOLICITATIONS

The above numbered solicitation is amended as set forth in Item 14. The hour and date specified for receipt of Offers is extended, is not extended.

Offers must acknowledge receipt of this amendment prior to the hour and date specified in the solicitation or as amended, by one of the following methods:

(a) By completing Items 8 and 15, and returning 3 copies of the amendment; (b) By acknowledging receipt of this amendment on each copy of the offer submitted;

or (c) By separate letter or telegram which includes a reference to the solicitation and amendment numbers. FAILURE OF YOUR ACKNOWLEDGMENT TO BE RECEIVED AT THE PLACE DESIGNATED FOR THE RECEIPT OF OFFERS PRIOR TO THE HOUR AND DATE SPECIFIED MAY RESULT IN REJECTION OF YOUR OFFER. If by virtue of this amendment you desire to change an offer already submitted, such change may be made by telegram or letter, provided each telegram or letter makes reference to the solicitation and this amendment, and is received prior to the opening hour and date specified.

12. ACCOUNTING AND APPROPRIATION DATA (If required)

13. THIS APPLIES ONLY TO MODIFICATIONS OF CONTRACTS/ORDERS.

IT MODIFIES THE CONTRACT/ORDER NO. AS DESCRIBED IN ITEM 14.

CHECK ONE A. THIS CHANGE ORDER IS ISSUED PURSUANT TO: (Specify authority) THE CHANGES SET FORTH IN ITEM 14 ARE MADE IN THE CONTRACT ORDER NO.

IN ITEM 10A.

B. THE ABOVE NUMBERED CONTRACT/ORDER IS MODIFIED TO REFLECT THE ADMINISTRATIVE CHANGES (such as changes in paying office, appropriation date, etc. ) SET FORTH IN ITEM 14, PURSUANT TO THE AUTHORITY OF FAR 43.103(b).

C. THIS SUPPLEMENTAL AGREEMENT IS ENTERED INTO PURSUANT TO AUTHORITY OF:

D. OTHER (Specify type of modification and authority)

E. IMPORTANT: Contractor is not, is required to sign this document and return copies to issuing office.

14. DESCRIPTION OF AMENDMENT/MODIFICATION (Organized by UCF section headings, including solicitation/contract subject matter where feasible.)

Opening/Closing Date Changed to:

2019 APR 30 / 2019 JUN 13

TIME 3:00 PM

See Attached Continuation Sheet(s).

Except as provided herein, all terms and conditions of the document referenced in Item 9A or 10A, as heretofore changed, remains unchanged and in full force and effect.

15A NAME AND TITLE OF SIGNER (Type or print) 16A. NAME AND TITLE OF CONTRACTING OFFICER (Type or print)

15B. CONTRACTOR/OFFEROR

(Signature of person authorized to sign)

15C. DATE SIGNED 16B. UNITED STATES OF AMERICA

(Signature of Contracting Officer)

16C. DATE SIGNED

NSN 7540-01-152-8070

Previous edition unusable

STANDARD FORM 30 (REV. 10-83)

Prescribed by GSA FAR (48 CFR) 53.243

CONTINUATION SHEET REFERENCE NO. OF DOCUMENT BEING CONTINUED: PAGE 2 OF 3 PAGES

SPE2D219R0042 - 0002

1. The closing date of the solicitation has been extended to 06/13/2019 03:00PM EST.

2. Line item 0017 Olanzapine 10MG 1 count vials have been removed from the solicitation.

3. Pages 2-4, 43-44, 49, 75-82 have been updated accordingly. See attached.

4. All other terms and conditions remain unchanged.

CONTINUED ON NEXT PAGE

CONTINUATION SHEET REFERENCE NO. OF DOCUMENT BEING CONTINUED: PAGE 3 OF 3 PAGES

SPE2D219R0042 - 0002

Attachments

List of Attachments

File Name Description ATTACH_backup amendment 0002 backup.

pdf

The following pages have been updated to reflect the changes:

Pages 2-4

ITEM NO.

20.

SCHEDULE OF SUPPLIES/SERVICES

21.

QUANTIT

Y

22.

UNIT

23.

UNIT

PRICE

24.

AMOUNT

0001AA

0001AB

0001AC

0001AD

0001AE

0002AA

0002AB

0002AC

0002AD

0002AE

0003AA

0003AB

0003AC

0003AD

0003AE

0004AA

0004AB

0004AC

0004AD

0004AE

0005AA

0005AB

0005AC

0005AD

0005AE

0006AA

0006AB

0006AC

0006AD

0006AE

0007AA

0007AB

0007AC

0007AD

0007AE

Olanzapine 2.5MG 30 count bottle* National Drug Code (NDC) ____-___-__ Base Year Option Year 1 Option Year 2 Option Year 3 Option Year 4

Olanzapine 2.5MG 1000 count bottle National Drug Code (NDC) ____-___-__ Base Year Option Year 1 Option Year 2 Option Year 3 Option Year 4

Olanzapine 5MG 30 count bottle* National Drug Code (NDC) ____-___-__ Base Year Option Year 1 Option Year 2 Option Year 3 Option Year 4

Olanzapine 5MG 1000 count bottle National Drug Code (NDC) ____-___-__ Base Year Option Year 1 Option Year 2 Option Year 3 Option Year 4

Olanzapine 7.5MG 30 count bottle* National Drug Code (NDC) ____-___-__ Base Year Option Year 1 Option Year 2 Option Year 3 Option Year 4

Olanzapine 7.5MG 1000 count bottle National Drug Code (NDC) ____-___-__ Base Year Option Year 1 Option Year 2 Option Year 3 Option Year 4

Olanzapine 10MG 30 count bottle* National Drug Code (NDC) ____-___-__ Base Year Option Year 1 Option Year 2 Option Year 3 Option Year 4

5,951

5,951

17,522

17,522

19,574

19,574

22,943

22,943

30,004

30,004

13,100

13,100

**BT

BT

BT

BT

BT

BT

BT

BT

BT

0008AA

0008AB

0008AC

0008AD

0008AE

0009AA

0009AB

0009AC

0009AD

0009AE

0010AA

0010AB

0010AC

0010AD

0010AE

0011AA

0011AB

0011AC

0011AD

0011AE

0012AA

0012AB

0012AC

0012AD

0012AE

0013AA

0013AB

0013AC

0013AD

0013AE

0014AA

0014AB

0014AC

0014AD

0014AE

0015AA

0015AB

0015AC

Olanzapine 10MG 1000 count bottle National Drug Code (NDC) ____-___-__ Base Year Option Year 1 Option Year 2 Option Year 3 Option Year 4

Olanzapine 15MG 30 count bottle* National Drug Code (NDC) ____-___-__ Base Year Option Year 1 Option Year 2 Option Year 3 Option Year 4

Olanzapine 15MG 1000 count bottle National Drug Code (NDC) ____-___-__ Base Year Option Year 1 Option Year 2 Option Year 3 Option Year 4

Olanzapine 20MG 30 count bottle* National Drug Code (NDC) ____-___-__ Base Year Option Year 1 Option Year 2 Option Year 3 Option Year 4

Olanzapine 20MG 1000 count bottle National Drug Code (NDC) ____-___-__ Base Year Option Year 1 Option Year 2 Option Year 3 Option Year 4

Olanzapine 5MG Rapids 30 count bottle* National Drug Code (NDC) ____-___-__ Base Year Option Year 1 Option Year 2

Olanzapine 10MG Rapids 30 count bottle* National Drug Code (NDC) ____-___-__ Base Year Option Year 1 Option Year 2 Option Year 3 Option Year 4

Olanzapine 15MG Rapids 30 count bottle* National Drug Code (NDC) ____-___-__ Base Year Option Year 1 Option Year 2

4,530

4,530

3,775

3,775

1,349

1,349

11,668

11,668

3,633

3,633

3,601

3,601

1,437

BT

BT

BT

BT

BT

BT

BT

Page 43-44

Tab A: Offeror's Proposed Price Offerors are required to provide pricing information for line items 0001- 0016. For CLIN 0001 offers shall include pricing for 5,951 2.5MG 30 count bottles. For CLIN 0002 offers shall include pricing for 17,522 2.5MG 1000 count bottles. For CLIN 0003 offers shall include pricing for 19,574 5MG 30 count bottles. For CLIN 0004 offers shall include pricing for 22,943 5MG 1000 count bottles. For CLIN 0005 offers shall include pricing for 30,004 7.5MG 30 count bottles. For CLIN 0006 offers shall include pricing for 108 7.5MG 1000 count bottles. For CLIN 0007 offers shall include pricing for 13,100 10MG 30 count bottles. For CLIN 0008 offers shall include pricing for 4,530 10MG 1000 count bottles. For CLIN 0009 offers shall include pricing for 3,775 15MG 30 count bottles. For CLIN 0010 offers shall include pricing for 1,349 15MG 1000 count bottles. For CLIN 0011 offers shall include pricing for 11,668 20MG 30 count bottles. For CLIN 0012 offers shall include pricing for 448 20MG 1000 count bottles. For CLIN 0013 offers shall include pricing for 3,633 5MG 30 count bottles (rapids). For CLIN 0014 offers shall include pricing for 3,601 10MG 30 count bottles (rapids). For CLIN 0015 offers shall include pricing for 1,437 15MG 30 count bottles (rapids). For CLIN 0016 offers shall include pricing for 1,078 20MG 30 count bottles (rapids). The offeror’s proposed prices are to be expressed in dollars as a unit price per bottle.

The offeror is required to submit its offered prices for each line item for the base and all option years as stated above as part of the offeror’s price proposal. The reverse auction process, telephonic negotiations and/or email negotiations may be used to determine the lowest price evaluated (unit price per bottle).

Extraneous Data: Offerors are not to include extraneous data such as, annual reports, marketing brochures, catalogs, etc.

In conducting the evaluation, the Defense Logistics Agency (DLA) will use information provided by the offeror in the proposal. The burden is on the offeror to provide a complete and thorough proposal. Proposals that are missing information or components identified above will be considered incomplete and may be eliminated from further consideration of award.

FAR 52.212-1 Addendum 3 -- Volume 2 - Price Proposal

0015AD

0015AE

0016AA

0016AB

0016AC

0016AD

0016AE

Olanzapine 20MG Rapids 30 count bottle* National Drug Code (NDC) ____-___-__ Base Year Option Year 1 Option Year 2

*Package size is unit of use and is subject to Statement of Work - “Preparation for Delivery” requirement.

** BT = Bottle

-The quantities specified in the Schedule are estimates only.

Reference FAR 52.216-21 Requirements for additional details.

1,078

1,078

BT

Organization of Offered Prices: Offerors are required to provide the following mandatory pricing information, expressed in dollars as a unit price per bottle, for line items 0001 through 0016:

The offeror is required to submit offered prices for each line item for the base and all option years as stated above as part of the offeror’s price proposal. The reverse auction process, telephonic negotiations and/or email negotiations may be used to determine the lowest price.

i. Lowest Evaluated Price.

After overall acceptable offers are identified; telephonic negotiations, email negotiations and/or reverse auction may be conducted for all offers in the competitive range. Offerors will be able to submit revised prices during discussions and the reverse auction process, if discussions and/or reverse auction processes are held.

Offerors are required to provide pricing information for line items 0001 through 0016. The offeror’s proposed prices are to be expressed in dollars as a unit price per bottle.

The offeror is required to submit its offered prices for each line item for the base and all option years as stated above as part of the offeror’s price proposal. The reverse auction process, telephonic negotiations and/or email negotiations may be used to determine the lowest price evaluated (unit price per bottle).

The overall lowest evaluated aggregate price will be determined by multiplying the estimated quantity for each line item, including options, by the offered unit price and then adding the total of each line.

Page 75 – the text below has been removed from the solicitation

LINE ITEM 0017: OLANZAPINE 10MG 1 COUNT VIAL

All prices exclusive of Federal Excise Tax:

Current (2019) Commercial List Price: ___________

Previous (2018) Commercial List Price: ___________

2019 Federal Supply Schedule Price: ___________

2018 Federal Supply Schedule Price: ___________

2019 Federal Ceiling Price ___________

2018 Federal Ceiling Price ___________

Pages 76-82 have been updated to the following:

TABLETS, CAPSULES AND PILLS

Item Complete Address of Facility Where Ingredients are Measured, Weighed, Mixed and Compounded

Point of Contact Including Phone Number

0001 – Olanzapine 2.5MG 30 count bottle

0002 – Olanzapine 2.5MG 1000 count bottle

0003 – Olanzapine 5MG

0004 – Olanzapine 5MG

0005 – Olanzapine 7.5MG

0006 – Olanzapine 7.5MG

0007 – Olanzapine 10MG

0008 – Olanzapine 10MG

0009 – Olanzapine 15MG

0010 – Olanzapine 15MG

0011 – Olanzapine 20MG

0012 – Olanzapine 20MG

0013 – Olanzapine 5MG rapids

0014 – Olanzapine 10MG rapids

0015 – Olanzapine 15MG rapids

0016 – Olanzapine 20MG rapids

PACKAGING

Item Complete Address of Facilities

Where Intermediate Containers will be Filled and Labeled

Point of Contact Including Phone Number

PACKING

Item Complete Address of Facilities

Where Products will be Packed and Prepared for Shipment

Point of Contact Including Phone Number

11. THIS ITEM ONLY APPLIES TO AMENDMENTS OF SOLICITATIONS
13. THIS APPLIES ONLY TO MODIFICATIONS OF CONTRACTS/ORDERS.
CONTINUATION SHEET REFERENCE NO. OF DOCUMENT BEING CONTINUED: PAGE 2 OF 3 PAGES SPE2D219R0042 - 0002

File details come from the government source that posted it.